<--- Back to Details
First PageDocument Content
Health / Pharmacology / Food safety / Pharmaceuticals policy / Clinical research / Food and Drug Administration / Compounding / New Drug Application / Positron emission tomography / Pharmaceutical industry / Medicine / Pharmaceutical sciences
Date: 2006-01-03 18:11:57
Health
Pharmacology
Food safety
Pharmaceuticals policy
Clinical research
Food and Drug Administration
Compounding
New Drug Application
Positron emission tomography
Pharmaceutical industry
Medicine
Pharmaceutical sciences

December 16,[removed]

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 777,83 KB

Share Document on Facebook

Similar Documents

The EVMS Autism Spectrum Disorder Program was started by Maria Urbano, M.D., and Kathrin Hartmann, Ph.D., in 2010 to provide clinical services, research, and community outreach to individuals and their families for Autis

DocID: 1vrwY - View Document

Towards a Composite Clinical Endpoint: Identifying a Core Set of Patient and Caregiver Relevant Outcome Measures Through Qualitative Research on the Global Impact of Dravet Syndrome Rima Nabbout1, Stephane Auvin2, Cather

DocID: 1vpIt - View Document

Clinical Research Registration at Public Registry

DocID: 1vnxr - View Document

Grattoni Alessandro, Ph.D. Chairman, The Department of Nanomedicine, The Houston Methodist Research Institute, Houston, Texas (USA) Dr. Grattoni’s research is dedicated to the development and clinical translation of im

DocID: 1vi9N - View Document

Clinical & Translational Research 101 Thursday, August 10, 2017 Time Location

DocID: 1vglz - View Document